Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer

Published:2021-11 Issue: Volume:50 Page:149-169
ISSN:1369-7021
Container-title:Materials Today
language:en
Short-container-title:Materials Today

Author:

Mu Qingxin,Lin Guanyou,Jeon Mike,Wang Hui,Chang Fei-Chien,Revia Richard A.,Yu John,Zhang Miqin

Funder

National Science Foundation

National Institutes of Health

Publisher

Elsevier BV

Reference106 articles.

1. Cancer statistics, 2020

2. Metastatic Breast Cancer: The Treatment Challenge

3. Breast Cancer Metastasis: Challenges and Opportunities

4. Triple-Negative Breast Cancer

5. Triple-negative breast cancer: is there a treatment on the horizon?

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M1 Macrophage Extracellular Vesicles and TLR3 Agonist Nanoparticles Down‐Regulate Immunosuppression and Metastasis via AKT/TAM in Triple‐Negative Breast Cancer;Molecular Carcinogenesis;2025-06-24

2. Breaking the barriers in effective and safe Toll-like receptor stimulation via nano-immunomodulators for potent cancer immunotherapy;Journal of Controlled Release;2025-06

3. Carbohydrate polymer-functionalized metal nanoparticles in cancer therapy: A review;International Journal of Biological Macromolecules;2025-05

4. Gamabufotalin loaded micro-nanocomposites for multimodal therapy of metastatic TNBC by efficiently inducing ICD;Biomaterials;2025-03

5. Harnessing the power of inorganic nanoparticles for the management of TNBC;International Journal of Pharmaceutics;2025-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP